Imported mycoses in Europe
Related Experiment Video
Updated: Oct 25, 2026
05:34
Sexual Crosses with the Mucoromycete Phycomyces blakesleeanus
Published on: June 6, 2025
D W Warnock1, B Dupont, C A Kauffman
1PHLS Mycology Reference Laboratory, Public Health Laboratory, Kingsdown, Bristol, UK.
Medical Mycology
|February 13, 1999
Abstract:
This article reviews the clinical manifestations, diagnosis and management of some of the more important systemic infections that are now being imported into Europe. It also considers the risks some of the causal organisms pose to European laboratory workers, many of whom are unfamiliar with the precautions that should be taken when handling these pathogens.
Insights
This review covers emerging systemic infections in Europe, detailing their clinical signs, diagnosis, and treatment. It also highlights risks to laboratory personnel handling these imported pathogens.
Area of Science:
- Infectious Diseases
- Public Health
- Microbiology
Background:
- Europe is experiencing an increase in imported systemic infections.
- Many European laboratory workers lack familiarity with handling novel pathogens.
- Understanding these infections is crucial for public health and occupational safety.
Purpose of the Study:
- To review the clinical features, diagnosis, and management of significant imported systemic infections in Europe.
- To assess the occupational risks posed by these pathogens to laboratory workers.
- To emphasize necessary safety precautions for handling unfamiliar infectious agents.
Main Methods:
- Literature review of clinical manifestations, diagnostic approaches, and treatment strategies.
- Analysis of potential risks associated with specific causal organisms.
- Discussion of recommended safety protocols for laboratory environments.
Main Results:
- Key systemic infections and their epidemiological trends in Europe are identified.
- Clinical presentations, diagnostic challenges, and effective management options are outlined.
- Specific pathogens posing risks to laboratory staff are highlighted, along with recommended precautions.
Conclusions:
- Clinicians and laboratory professionals require updated knowledge on imported infections.
- Implementing stringent safety measures is essential to protect laboratory workers.
- Proactive management and awareness are vital for controlling the spread of these diseases.
Related Concept Videos
01:23Skin Diseases and Disorders
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:28Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:28Fungal Phylum Ascomycota
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...